Dupilumab and lymphoma risk among patients with asthma
<title>Extract</title> The article by M<sc>a</sc> <italic>et al.</italic> [1] suggested that lower all-cause mortality along with a putative increased lymphoma risk was associated with dupilumab use in asthma. There are several methodological issues with the data which may have affected its interpretation.
Authors
- Philipp Suter (ORCID: https://orcid.org/0000-0003-1426-4544)
- Robert Greig
- Brian Lipworth
Institutions
- University of Dundee (GB)
Publication Details
- Journal
- European Respiratory Journal
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1183/13993003.01380-2025
- Primary Topic
- Statistical Methods in Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00